Literature DB >> 33827468

A bibliometric analysis of researches on flap endonuclease 1 from 2005 to 2019.

Qiaochu Wei1, Jiming Shen1, Dongni Wang1, Xu Han1, Jing Shi1, Lei Zhao1, Yuee Teng2.   

Abstract

BACKGROUND: Flap endonuclease 1 (FEN1) is a structure-specific nuclease that plays a role in a variety of DNA metabolism processes. FEN1 is important for maintaining genomic stability and regulating cell growth and development. It is associated with the occurrence and development of several diseases, especially cancers. There is a lack of systematic bibliometric analyses focusing on research trends and knowledge structures related to FEN1.
PURPOSE: To analyze hotspots, the current state and research frontiers performed for FEN1 over the past 15 years.
METHODS: Publications were retrieved from the Web of Science Core Collection (WoSCC) database, analyzing publication dates ranging from 2005 to 2019. VOSviewer1.6.15 and Citespace5.7 R1 were used to perform a bibliometric analysis in terms of countries, institutions, authors, journals and research areas related to FEN1. A total of 421 publications were included in this analysis.
RESULTS: Our findings indicated that FEN1 has received more attention and interest from researchers in the past 15 years. Institutes in the United States, specifically the Beckman Research Institute of City of Hope published the most research related to FEN1. Shen BH, Zheng L and Bambara Ra were the most active researchers investigating this endonuclease and most of this research was published in the Journal of Biological Chemistry. The main scientific areas of FEN1 were related to biochemistry, molecular biology, cell biology, genetics and oncology. Research hotspots included biological activities, DNA metabolism mechanisms, protein-protein interactions and gene mutations. Research frontiers included oxidative stress, phosphorylation and tumor progression and treatment.
CONCLUSION: This bibliometric study may aid researchers in the understanding of the knowledge base and research frontiers associated with FEN1. In addition, emerging hotspots for research can be used as the subjects of future studies.

Entities:  

Keywords:  Bibliometrics; Cancer; Citespace; Flap endonuclease 1

Year:  2021        PMID: 33827468     DOI: 10.1186/s12885-021-08101-2

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  27 in total

Review 1.  Flap endonuclease 1: a novel tumour suppresser protein.

Authors:  Ghislaine Henneke; Erica Friedrich-Heineken; Ulrich Hübscher
Journal:  Trends Biochem Sci       Date:  2003-07       Impact factor: 13.807

2.  Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma.

Authors:  Joel Isohookana; Kirsi-Maria Haapasaari; Ylermi Soini; Joni Leppänen; Peeter Karihtala
Journal:  Pathol Res Pract       Date:  2018-05-01       Impact factor: 3.250

Review 3.  The FEN-1 family of structure-specific nucleases in eukaryotic DNA replication, recombination and repair.

Authors:  M R Lieber
Journal:  Bioessays       Date:  1997-03       Impact factor: 4.345

Review 4.  Enzymes and reactions at the eukaryotic DNA replication fork.

Authors:  R A Bambara; R S Murante; L A Henricksen
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

5.  Cell cycle-dependent and DNA damage-inducible nuclear localization of FEN-1 nuclease is consistent with its dual functions in DNA replication and repair.

Authors:  J Qiu; X Li; G Frank; B Shen
Journal:  J Biol Chem       Date:  2000-10-25       Impact factor: 5.157

6.  Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.

Authors:  Keqiang Zhang; Sawa Keymeulen; Rebecca Nelson; Tommy R Tong; Yate-Ching Yuan; Xinwei Yun; Zheng Liu; Joshua Lopez; Dan J Raz; Jae Y Kim
Journal:  Am J Pathol       Date:  2017-10-14       Impact factor: 4.307

7.  Evidence for a role of FEN1 in maintaining mitochondrial DNA integrity.

Authors:  Lidza Kalifa; Gisela Beutner; Naina Phadnis; Shey-Shing Sheu; Elaine A Sia
Journal:  DNA Repair (Amst)       Date:  2009-08-21

Review 8.  Flap endonuclease 1: a central component of DNA metabolism.

Authors:  Yuan Liu; Hui-I Kao; Robert A Bambara
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.

Authors:  Tarek M A Abdel-Fatah; Roslin Russell; Nada Albarakati; David J Maloney; Dorjbal Dorjsuren; Oscar M Rueda; Paul Moseley; Vivek Mohan; Hongmao Sun; Rachel Abbotts; Abhik Mukherjee; Devika Agarwal; Jennifer L Illuzzi; Ajit Jadhav; Anton Simeonov; Graham Ball; Stephen Chan; Carlos Caldas; Ian O Ellis; David M Wilson; Srinivasan Madhusudan
Journal:  Mol Oncol       Date:  2014-05-13       Impact factor: 6.603

Review 10.  Functional regulation of FEN1 nuclease and its link to cancer.

Authors:  Li Zheng; Jia Jia; L David Finger; Zhigang Guo; Cindy Zer; Binghui Shen
Journal:  Nucleic Acids Res       Date:  2010-10-06       Impact factor: 16.971

View more
  4 in total

1.  Worldwide Research Trends on Artemisinin: A Bibliometric Analysis From 2000 to 2021.

Authors:  Yankai Dong; Lina Liu; Jie Han; Lianqing Zhang; Yi Wang; Juan Li; Yuexiang Li; He Liu; Kun Zhou; Luyao Li; Xin Wang; Xue Shen; Meiling Zhang; Bo Zhang; Xiaofei Hu
Journal:  Front Med (Lausanne)       Date:  2022-05-06

2.  Hotspots and trends in liver kinase B1 research: A bibliometric analysis.

Authors:  Yaowen Song; Fangkun Zhao; Wei Ma; Guang Li
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

3.  A bibliometric and emerging trend analysis on stress granules from 2011 to 2020: A systematic review and bibliometrics analysis.

Authors:  Haiyang Yu; Qinhao Chen; Yueyin Pan
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

4.  Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors.

Authors:  Yuanxia Liu; Qianxia Liu; Xiaolian Jiang
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.